OCTOBER 27, 2005

Company

Altimmune, Inc.

Filed

October 27, 2005

Accession Number

0001013594-05-000457

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →